Corporate Banner
Satellite Banner
Scientific Communities
Become a Member | Sign in
Home>News>This Article

Good Start Genetics® Announces The Expansion of its NGS-Based Carrier Screening Service

Published: Friday, October 26, 2012
Last Updated: Friday, October 26, 2012
Bookmark and Share
The announcement means that Good Start Genetics' screening service, GoodStart Select™, now offers state-of-the-art testing for all 23 of the diseases recommended in guidelines set by the major medical societies.

Good Start's screening services centers on the revolutionary, next- generation DNA sequencing platform - which can detect far more disease-causing mutations than the older, genotyping-based platform - with the goal of providing the highest carrier detection rates possible.

In addition to its menu of pan-ethnic tests (e.g. cystic fibrosis, fragile X syndrome and spinal muscular atrophy), tests for hemoglobinopathies (sickle cell anemia, alpha thalassemia and beta thalassemia) and routine tests for the Ashkenazi Jewish population, Good Start now offers the following additional tests: dihydrolipoamide dehydrogenase deficiency, familial hyperinsulinism, glycogen storage disease type 1a, Joubert syndrome 2, maple syrup urine diseases type A/B, nemaline myopathy, Usher syndrome type 1F, Usher syndrome type III, and Walker-Warburg syndrome.

Good Start performs testing in its CAP- and CLIA-accredited, state-of-the-art laboratory facility located in Cambridge, MA, and has built a dedicated team of customer care specialists, genetic counselors and board certified medical geneticists to support patients and clinics. Good Start works closely with patients and their insurance providers to simplify the billing and payment process. In addition, as part of its mission to provide accurate, simple and responsible testing, Good Start has launched a new web site, which includes patient and physician-friendly tools that facilitate in the test selection process. (Good Start's test menu can be customized for each patient based on family history, patient ethnicity, or any other criteria the clinician deems important.)

"Reproductive healthcare professionals have long followed guideline recommendations for carrier screening for their patients planning pregnancy," said Michael Alper, M.D., Medical Director & Reproductive Endocrinologist, Boston IVF. "However, conventional screening methods have, to date, been limited by either their rigidity or the relatively small number of mutations that can be analyzed in a specific gene. Given recent advancements with the next-generation sequencing technology, we are pleased to be able to offer Good Start's technology to our patients in routine clinical practice."

"We are excited to make these additional tests available, and to meet the growing screening needs of new families and those wishing to start families," said Don Hardison, Good Start Genetics President and Chief Executive Officer. "And, using our next generation sequencing platform, we are already detecting mutations that other laboratories simply cannot. With this powerful technology, combined with our intense customer focus, we are confident we are delivering the best screening experience possible for patients and clinicians and, most importantly, critical information that can help increase a couple's chance of having a healthy baby. As a result, we expect that our sequencing-based approach to screening will continue to replace older, genotyping-based approaches and solidify our reputation as a leader in the carrier screening market."

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More Than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Genetic Basis of Fatal Flu Side Effect Discovered
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
New Tech Vastly Improves CRISPR/Cas9 Accuracy
A new CRISPR/Cas9 technology developed by scientists at UMass Medical School is precise enough to surgically edit DNA at nearly any genomic location, while avoiding potentially harmful off-target changes typically seen in standard CRISPR gene editing techniques.
The MaxSignal Colistin ELISA Test Kit from Bioo Scientific
Kit can help prevent the antibiotic apocalypse by keeping last resort drugs out of the food supply.
"Good" Mozzie Virus Might Hold Key to Fighting Human Disease
Australian scientists have discovered a new virus carried by one of the country’s most common pest mosquitoes.
Non-Disease Proteins Kill Brain Cells
Scientists at the forefront of cutting-edge research into neurodegenerative diseases such as Alzheimer’s and Parkinson’s have shown that the mere presence of protein aggregates may be as important as their form and identity in inducing cell death in brain tissue.
Closing the Loop on an HIV Escape Mechanism
Research team finds that protein motions regulate virus infectivity.
New Class of RNA Tumor Suppressors Identified
Two short, “housekeeping” RNA molecules block cancer growth by binding to an important cancer-associated protein called KRAS. More than a quarter of all human cancers are missing these RNAs.
Potential Treatment for Life-Threatening Viral Infections Revealed
The findings point to new therapies for Dengue, West Nile and Ebola.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos